Advanced Cell Technology, Inc. Share Price OTC Bulletin Board

Stocks

End-of-day quote OTC Bulletin Board
- ^USD	-

10/16/10	Ocata Therapeutics : Astellas Announces Results of Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics and Changes to Subsidiaries	PR
22/16/22	Ocata Therapeutics : Astellas Extends Tender Offer to Acquire All Outstanding Shares of Ocata Therapeutics	PR
28/15/28	Ocata Therapeutics : Reports the Publication of Data about the Generation of Corneal Endothelial Cells from Human Pluripotent Stem Cells	BU
03/15/03	Ocata Therapeutics : Hemangio-derived Mesenchymal Cells Preserve Kidney Function and Extend Lifespan in Preclinical Model of Lupus Nephritis	BU
11/15/11	OCATA THERAPEUTICS : Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Merger with Astellas Pharma Inc.	BU

Manager	Title	Age	Since
John Heffernan PRN	Corporate Officer/Principal	-	03/02/2015

Director	Title	Age	Since
Toru Yoshimitsu BRD	Director/Board Member	63	-
Masaaki Hirano BRD	Director/Board Member	59	-
Percival Barretto-Ko BRD	Director/Board Member	53	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WUXI APPTEC CO., LTD.	+4.16%	+3.04%	+49.37%	+94.17%	7.44TCr
ARGENX SE	-0.61%	+0.81%	+27.25%	+82.72%	5.93TCr
LONZA GROUP AG	-2.54%	-1.65%	+4.86%	+31.72%	4.71TCr
IQVIA HOLDINGS INC.	-3.02%	-5.20%	+27.94%	+32.51%	4.29TCr
REVOLUTION MEDICINES, INC.	+0.31%	+3.02%	+348.95%	+643.82%	4.41TCr
BEONE MEDICINES AG	-1.96%	-0.33%	+7.04%	+99.46%	4.08TCr
CELLTRION, INC.	+3.32%	+3.49%	+10.10%	+51.23%	3.08TCr
WUXI BIOLOGICS (CAYMAN) INC.	-2.94%	+2.64%	+29.28%	+22.38%	2.93TCr
INSMED INCORPORATED	-4.86%	-10.66%	-26.27%	+330.06%	2.37TCr
Average	-0.90%	-0.52%	+53.17%	+154.23%	4.36TCr
Weighted average by Cap.	-0.36%	-0.32%	+58.48%	+146.08%